hat
Okenn nan SARMs poud lan ankò devlope yo vrèman selektif pou efè anabolik nan misk oswa zo tisi san yo pa pwodwi nenpòt ki efè Androjenik nan tisi tankou glann pwostat la, sepandan plizyè endwògoyèn endrojin montre yon rapò nan anabolik efè androjenik nan pi gran pase 3: 1 ak jiska otan ke 90: 1 (RAD-140), konpare ak testostewòn, ki te gen yon rapò nan 1: 1.
eng
None of the SARMs powder yet developed are truly selective for anabolic effects in muscle or bone tissues without producing any androgenic effects in tissues such as the prostate gland, however several nonsteroidal androgens show a ratio of anabolic to androgenic effects of greater than 3:1 and up to as much as 90:1 (RAD-140), compared to testosterone, which has a ratio of 1:1.